Peter Llewellyn-Davies

Peter Llewellyn-Davies has over 25 years of experience in the pharmaceutical and biotech industry. Peter is currently the CEO and CFO of APEIRON Biologics.

Previously, they were a board member and non-executive director at immunocore from October 2012 to November 2014. From September 2012 to April 2016, they served as the Chief Financial Officer and CBO of medigene ag. Peter was also the Chief Financial Officer of wilex ag from September 2006 to September 2012.

From March 2003 to April 2005, they were the Executive Director of Finance and Administration at müller uk & ireland group. Prior to that, they were the Executive Director of Finance, Controlling and Accounting at sud-chemie from October 1996 to March 2003.

Peter is also the founder and CEO of ACCELLERATE Partners GmbH and has been a non-executive director at wilex since March 2009. Peter is also a partner at bane business angel network europe gbr and the owner of cfo-on-demand pld management service.

Peter Llewellyn-Davies attended the London Institute of Banking & Finance, the University of London, and Westcliff High School in the UK.

Some individuals on their team include Kerstin Westritschnig - Chief Medical Officer, Oliver Mutschlechner - Chief Development Officer, and Andreas Stadler - Director of Finance.